Phase 2 Crohn's Disease and Colitis Trial, Recruiting (NCT05575505)

Phase 2 Crohn's Disease and Colitis Trial, Recruiting NCT05575505 Sponsor: Tanta University Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT05575505 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
Both men and women are eligible to participate
People who have a negative pregnancy test and are using effective contraception

Who may not be able to join:

People who are currently breastfeeding
People who have significant problems with their liver or kidney function
People who have colorectal (bowel) cancer
People who have severe ulcerative colitis
People who are currently using steroid treatments, either applied rectally or taken throughout the body (such as tablets or injections)
People who are currently taking medications that suppress the immune system, or biological therapies (medicines made from living cells)
People with an addiction to alcohol and/or drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05575505

Sponsor: Tanta University

Phase: Phase 2

Status: Recruiting

Condition: Crohn's Disease and Colitis

More information: https://clinicaltrials.gov/study/NCT05575505

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
Both men and women are eligible to participate
People who have a negative pregnancy test and are using effective contraception

Who may not be able to join:

People who are currently breastfeeding
People who have significant problems with their liver or kidney function
People who have colorectal (bowel) cancer
People who have severe ulcerative colitis
People who are currently using steroid treatments, either applied rectally or taken throughout the body (such as tablets or injections)
People who are currently taking medications that suppress the immune system, or biological therapies (medicines made from living cells)
People with an addiction to alcohol and/or drugs

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Tanta University

Registry

ClinicalTrials.gov

Start date

2 February 2023

Est. completion

1 February 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

changes in Mayo Score Index.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov